Granite Point Capital Management, L.P. Spectrum Pharmaceuticals Inc Put Options Transaction History

Granite Point Capital Management, L.P.

2 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q1 2020 May 12, 2020	SELL	$1.83 - $3.45 $366,000 - $690,000	-200,000 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$3.5 - $10.35 $700,000 - $2.07 Million	200,000 New	200,000 $728,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Granite Point Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Granite Point Capital Management, L.P. with notifications on news.